波罗样酶4通过酸化EphA2加速质瘤恶性进展和血管仿真
Bo Wang1, Run-Ze Yu1, Xiao-Yang Zhang1
1Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury, Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Cancer letters
|December 18, 2024
概括
波罗样类激酶4 (PLK4) 通过促进血管生成模拟 (VM) 来驱动质母细胞瘤的进展和抗血管生成疗法的耐药性. 抑制PLK4的作用
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤 (GBM) 表现出对抗血管原体疗法的耐药性,部分原因是瘤细胞的血管原体仿真 (VM).
- 波罗样酶4 (PLK4) 涉及到GBM的进展,并与预后不佳有关.
研究的目的:
- 研究PLK4在GBM进展和VM形成中的作用.
- 阐明PLK4影响VM和治疗耐药性的分子机制.
主要方法:
- 蛋白质组学和光蛋白质组学被整合起来,以确定PLK4的目标.
- 这项研究研究了PLK4对EphA2的酸化及其下游信号.
- 评估了在质瘤组织中PLK4表达和EphA2酸化之间的相关性.
主要成果:
- 在Ser901和Ser897上,PLK4直接酸化EphA2,激活PI3K-Akt和MAPK信号级联.
- 通过PLK4介导的EphA2 Ser901酸化增强了EphA2 Ser897酸化,这是EphA2激活的标志物.
- PI3K-Akt信号与VM进展有关,表明PLK4通过EphA2.2在VM中的作用.
- 在GBM组织中,PLK4蛋白水平与EphA2酸化具有正相关性.
结论:
- 通过激活EphA2信号传递,PLK4促进质母细胞瘤恶性瘤和VM形成.
- 准PLK4-介导的EphA2酸化可能提供一种治疗策略来对抗GBM中的血管生成抵抗.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


